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Abstract
Classification of histologic patterns in lung adenocar-
cinoma is critical for determining tumor grade and treat-
ment for patients. However, this task is often challeng-
ing due to the heterogeneous nature of lung adenocarci-
noma and the subjective criteria for evaluation. In this
study, we propose a deep learning model that automati-
cally classifies the histologic patterns of lung adenocarci-
noma on surgical resection slides. Our model uses a con-
volutional neural network to identify regions of neoplastic
cells, then aggregates those classifications to infer predom-
inant and minor histologic patterns for any given whole-
slide image. We evaluated our model on an independent
set of 143 whole-slide images. It achieved a kappa score of
0.525 and an agreement of 66.6% with three pathologists
for classifying the predominant patterns, slightly higher
than the inter-pathologist kappa score of 0.485 and agree-
ment of 62.7% on this test set. All evaluation metrics for
our model and the three pathologists were within 95% con-
fidence intervals of agreement. If confirmed in clinical prac-
tice, our model can assist pathologists in improving classi-
fication of lung adenocarcinoma patterns by automatically
pre-screening and highlighting cancerous regions prior to
review. Our approach can be generalized to any whole-slide
image classification task, and code is made publicly avail-
able at https://github.com/BMIRDS/deepslide.
1. Introduction
Lung carcinoma is the leading cause of cancer death
among both men and women in the United States and the
western world.1 It is classified into small cell neuroen-
docrine carcinoma and non-small cell carcinoma, of which
∗jason.20@dartmouth.edu
†saeed.hassanpour@dartmouth.edu
adenocarcinoma is the most common histologic type, ac-
counting for about half of all cases.2 Treatment for lung
adenocarcinoma is based on the grade and stage of the tu-
mor, which is determined largely by pathologists’ evalua-
tion of the tumor’s histology. In 2015, the World Health Or-
ganization released its most recent guidelines for the classi-
fication of non-mucinous lung adenocarcinoma, identifying
five histologic patterns (subtypes): lepidic, acinar, papillary,
micropapillary, and solid.3,4 Furthermore, these guidelines
recommend comprehensive documentation of minor com-
ponents in addition to the predominant subtype, since lung
adenocarcinomas frequently contain a heterogenous mix of
multiple patterns.
Classification of adenocarcinoma histology patterns is
important because it provides significant insight into pa-
tient prognosis and survival. For instance, identification
of pure lepidic pattern has been shown to have excellent
prognoses for stage I lung cancer patients and is typi-
cally classified as low grade.5−9 Acinar and papillary pat-
terns are classified as intermediate grade, while micropap-
illary and solid patterns are high grade and are associated
with poor prognoses.6,10−13 Patients with micropapillary
or solid predominant patterns have lower survival rates, so
they are more likely to undergo and benefit from adjuvant
chemotherapy.14
Identifying the histologic subtypes in adenocarcinoma is
extremely important for tumor prognosis and treatment, but
accurate classification of such patterns can be challenging.
About 80% of adenocarcinoma cases contain a mixed spec-
trum of multiple histologic patterns,15 and the qualitative
criteria used for classification tends to induce inter-observer
variability among pathologists. One study found that differ-
ent appraisals of the maintenance or loss of alveolar struc-
tures resulted in varying classifications of acinar and lep-
idic patterns, and that major-minor classification of papil-
lary and micropapillary subtypes was contentious when the
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Figure 1: Overview of whole-slide classification of histologic patterns. We used a sliding window approach on the whole
slide to generate small patches, classified each patch with a residual neural network, aggregated the patch predictions, and
used a heuristic to determine predominant and minor histologic patterns for the whole slide. Patch predictions were made
independently of adjacent patches and relative location in the whole-slide image.
two were intermixed.16 Moreover, even small amounts of
high grade patterns that are easily overlooked have been
shown to be associated with significantly worse prognoses,
especially for the micropapillary subtype.17,18 The subjec-
tive nature of classifying such patterns has motivated sev-
eral studies on the agreement of histologic subtype classi-
fications among pathologists. One report revealed moder-
ate to good kappa scores of 0.44-0.72 among pulmonary
pathologists, and fair kappa scores of 0.38-0.47 among res-
idents; intra-observer variability yielded kappa scores of
0.79-0.87.19 Another survey of expert pulmonary patholo-
gists found kappa scores of 0.70-0.84 for classical images
and kappa scores of 0.24-0.52 for difficult cases.20
Recent advances in artificial intelligence, particularly in
the field of deep learning, have produced a set of image
analysis techniques that automatically extract relevant fea-
tures using a data-driven approach. One class of these deep
learning models is convolutional neural networks, which
have enabled researchers to create compelling algorithms
for medical image analysis.21,22 For pulmonary disease in
particular, deep learning has already shown potential to as-
sist pathologists in chest x-ray analysis, interstitial lung dis-
ease classification, and nodule detection.23 The presented
study is the first attempt to use emerging deep learning tech-
nology for automated classification of histologic subtypes
on lung adenocarcinoma surgical resection slides.
2. Results
A deep learning model for classification of whole-slide
images. This study presents a deep learning model for au-
tomated classification of histologic subtypes on lung ade-
nocarcinoma histopathology slides. Our model uses a patch
classifier combined with a sliding window approach to iden-
tify both major and minor patterns on a given whole-slide
image, as shown in Figure 1. We used 422 whole-slide im-
ages collected from the Dartmouth-Hitchcock Medical Cen-
ter in Lebanon, NH, which were randomly split into three
sets: training, development, and test (Table 1). For final
evaluation, we compared our model’s classification of 143
whole-slide images in the independent test set to those of
three pathologists.
Training Set Development Set Test Set Total
Pattern WSI Crops WSI Patches WSI WSI
Lepidic 99 515 17 58 64 180
Acinar 115 692 23 269 82 220
Papillary 9 44 3 65 5 17
Micropapillary 41 412 9 50 22 72
Solid 68 425 9 400 54 131
Benign - 2,073 - 226 - -
Total 245 4,161 34 1,068 143 422
Table 1: Distribution of training, development, and test
set data among five histologic patterns and benign cases.
WSI denotes whole slide image. Crops are variable length
and width and annotated by pathologists, while patches are
square and of fixed size, obtained from sliding a window
over crops. The class distribution for WSI’s in our test set
are the average of the labels from three pathologists.
Accurate classification of classical examples of histologic
subtypes. For selection of the best neural network archi-
tecture, we validated our model against the development
set of classic examples of histologic patterns. The best
model achieved an F1 score of 90.4% on this set of patches.
The per-class evaluation metrics of precision, recall, and
F1 score are shown in Figure 2A with their corresponding
95% confidence intervals. In addition, we plotted the Re-
ceiver Operating Characteristic (ROC) curves of our model
for each histologic class in Figure 2B. Our patch classi-
fier achieved an area under the curve (AUC) greater than
or equal to 0.97 for all classes.
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Figure 2: Models performance on the 1,068 classic samples for histologic patterns. A: patch classification results with 95%
confidence intervals. B: ROC curves and their area under the curves (AUCs) on this development set.
Kappa Score Agreement (%) R. Agreement (%)
Pathologist 1 0.454 (0.372-0.536) 61.3 (53.3-69.3) 66.9 (59.2-74.6)
Pathologist 2 0.515 (0.433-0.597) 64.8 (57.0-72.6) 72.3 (65.0-79.6)
Pathologist 3 0.514 (0.432-0.596) 63.1 (55.2-71.0) 75.4 (68.3-82.5)
Inter-pathologist 0.479 (0.397-0.561) 62.7 (54.8-70.6) 71.5 (64.1-78.9)
Baseline model24 0.445 (0.364-0.526) 60.1 (52.1-68.1) 69.0 (61.4-76.6)
Our model 0.525 (0.443-0.607) 66.6 (58.9-74.3) 76.7 (69.8-83.6)
Table 2: Comparison of pathologists and our model for
classification of predominant subtypes in 143 whole-slide
images in our test set. Average kappa score is calculated
by averaging pairs of an annotators kappa scores. For in-
stance, Pathologist 1 average is calculated by averaging the
kappa scores of Pathologist 1 & Pathologist 2, Pathologist
1 & Pathologist 3, and Pathologist 1 & our model. Aver-
age agreement was calculated in the same fashion. Robust
agreement (R. Agreement) indicates agreement for an an-
notator with at least two of the three other annotators. 95%
confidence intervals are shown in parentheses.
Comparison of deep learning model to pathologists. Our
model was evaluated against pathologists on an indepen-
dent test set of 143 whole-slide images. The kappa scores
for predominant classification between every pair of anno-
tators/model are shown in Figure 3A. In addition, Figure 3B
shows the percentage of agreements on the predominant his-
tologic patterns among our pathologist annotators and the
final model. Figure 3C shows the kappa score for the detec-
tion of each histologic pattern, regardless of predominant or
minor subtype. Table 2 summarizes the metrics in Figure
3A and Figure 3B through average kappa scores and av-
erage predominant agreement among the annotators/model.
Notably, our model edges out inter-pathologist agreement
measures with an average kappa score of 0.525 and an av-
erage predominant agreement of 66.6%. Furthermore, for
each annotator we calculated a metric called “robust agree-
ment”, which indicates the annotator’s agreement with at
least two of the three other annotators. We performed a two-
sample t-test for means on each pair of metrics in Figure 3A
and Figure 3B, and found that our model and all patholo-
gists’ performances were within 95% confidence intervals
of agreement for every pair of metrics. For comparison,
we also implemented the method used in Coudray et al. as
a baseline.24 Their method classified adenocarcinoma and
squamous cell carcinoma slides by averaging the predicted
probability of patches. We extended this methodology for
a multi-label classification baseline in our study. Finally,
Figure 4 depicts the visualization of the histologic patterns
identified by our model on sample whole-slide images. A
subjective qualitative investigation by our pathologist anno-
tators confirmed that the patterns detected on each slide are
on target.
3. Discussion
Our model is statistically on par with pathologists for
all evaluated metrics on our test set of 143 whole-slide im-
ages. For all pairs of pathologists/model, Kpredom was in
the moderate (0.41-0.60) range, with predominant agree-
ment around sixty to sixty-five percent. Our model slightly
edged out the pathologists on these two metrics, possibly
because computing tumor areas by counting the number of
patches is more precise than unaided estimations of tumor
area by the naked eye. Of all disagreements in predominant
subtype classification, 39.5% were between the acinar and
lepidic subtypes, a finding that is consistent with the fact
that the two patterns often appear together, and it can be
challenging to define an exact border between these two pat-
terns. Detection of minor patterns, on the other hand, was
more challenging both for pathologists and for our model.
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Figure 3: Model’s classification of 143 whole-slide images
in the test set compared to those of three pathologists. A:
the kappa score of the predominant classification among all
pairs of annotations. B: agreement percentages of predomi-
nant classification among all pairs of annotations. C: kappa
scores for each histologic pattern among all pairs of annota-
tions regardless of predominant or minor subtypes. P1, P2,
and P3 are Pathologist 1, Pathologist 2, and Pathologist 3
respectively.
This is likely due to the fact that patterns that occur in
small amounts can be interpreted differently or easily over-
looked, leading to higher levels of disagreement among an-
notators. Our model was evaluated on an unbiased dataset
from all available adenocarcinoma lobectomy slides since
2016 available at our institution and performs at least on par
with pathologists in identifying the predominant and minor
histologic subtypes. Of note, we are not aware of any other
existing model for automated classification of lung adeno-
carcinoma patterns.
An automated system for detecting and visualizing his-
tologic patterns of lung adenocarcinoma has a wide variety
of applications in clinical settings. Considering the quick
turnaround time of our model, it could be integrated into
existing laboratory information management systems to au-
tomatically pre-populate diagnoses for histologic patterns
on slides or provide a second opinion on more challenging
patterns. In addition, a visualization of the entire slide, ex-
amined by our model at the piecewise level, could highlight
elusive areas of high-grade patterns as well as primary re-
gions of tumor cells. Also, our model could expedite the tu-
mor diagnosis process by automatically requesting genetic
testing for certain patients based on the histologic patterns
detected, allowing clinicians to diagnose and treat patients
faster. The application of our model in a clinical setting,
which our research team will pursue as a next step, is essen-
tially an automated platform for quality assurance in read-
ing histologic slides of lung adenocarcinoma. A successful
implementation of this system will support more accurate
classification of lung cancer grade and ultimately facilitate
the entire process of lung cancer diagnosis.
The model presented in this paper is rooted in strong
deep learning methodology and achieves pathologist-level
performance on the test set. However, one limitation is that
our study is conducted on data from a single medical center,
so our data may not necessarily be representative of all lung
adenocarcinoma histology patterns. Although our whole-
slide scans are of high resolution and we were able to use
image augmentation to generate a large number of train-
ing samples, our dataset is relatively small in relation to
classical deep learning datasets, many of which have more
than ten thousand unique examples per class25,26 and more
than a million unique images in total.27 In particular, the
papillary and micropapillary classes were extremely rare in
our dataset, only represented in four and seventeen percent
of the whole-slides images in our training set, respectively.
Collection of more images through collaboration with other
medical centers would allow us to refine our model on a
more diverse dataset and will be pursued as future research.
Previous work has been done involving deep learning
and lung cancer pathology images. In several studies, The
Cancer Genome Atlas (TCGA) data was used to predict
prognosis using computational methods.28−30 While these
papers have revealed meaningful correlations between tis-
sue features and survival rates, their performances are not
high enough to be used reliably in clinical practice. A recent
study used TCGA data to predict mutations and distinguish
between adenocarcinoma and squamous cell carcinoma.24
Our work is novel in several ways. First, to the best of
our knowledge, our study is the first to automate classifi-
cation of histologic subtypes, a task that can be challenging
even for experienced pathologists. Furthermore, we demon-
strated a novel threshold-based aggregation method that
yields performance surpassing those of previous studies,24
allowing our model to be generalized to multi-class and
multi-label tasks. Finally, while all previous work was done
on frozen slides that are not typically used by pathologists
for visual inspection, our model is trained on a comprehen-
sively annotated set of formalin-fixed paraffin-embedded
(FFPE) histopathology slides.
Moving forward, more work can be done to further the
capabilities of our model. Possible improvements to our
present architecture could include drawing bounding boxes
around cancerous regions using region-based convolutional
neural networks (R-CNN)31 or outlining regions of inter-
est at the pixel level using Mask-RCNN.32 This would re-
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Figure 4: Visualization of the histologic patterns annotated by pathologists (A.i-iv), compared to those detected by our model
(B.i-iv).
quire a larger and more laboriously annotated dataset but
could help pathologists recognize exactly which cellular
structures the model identifies as cancerous. In addition,
the predictions from our model can be tested for potential
correlation with patient outcomes. Several previous stud-
ies have shown that even small amounts of the micropapil-
lary pattern, which could be easily concealed on a whole-
slide image, have been associated with extremely poor
prognoses.17,18 A study of our model’s detection of mi-
cropapillary subtype compared to those of pathologists for
patients who had unexpectedly worse survival rates could
potentially shed insight on elusive histologic patterns easily
missed by pathologists. In addition, studies have shown that
certain histologic patterns are associated with specific mu-
tations in EGFR, ALK, ROS1, and KRAS genes,33−36 and
that these mutations can be predicted by using deep neural
networks on frozen slides.37 With an appropriate dataset,
our model could be re-trained to directly predict genetic mu-
tations from FFPE slides and identify patients who require
genetic screening and targeted therapy. To this end, we will
continue our collaboration with the Pathology and Labora-
tory Medicine Department at our institution to retrieve the
pathology reports and genetic screening results for the col-
lected images in our current dataset, with the aim of training
a model that can also predict genetic mutations and survival
outcomes.
In this study, we proposed a deep learning model for
classifying predominant and minor histologic patterns on
lung adenocarcinoma whole-slide images. Our model
consists of a residual convolutional neural network for
patch classification combined with a whole-slide inferenc-
ing mechanism for determining predominant and minor
subtypes on the whole slide. On an independent test set,
our model performed on par with pathologists. The visual-
ization of our results and a qualitative investigation by our
pathologist annotators confirms that our model’s classifica-
tions are generally on target. Our model can potentially be
used to aid pathologists in classification of these histologic
patterns and ultimately contribute to more accurate grading
of lung adenocarcinoma.
4. Materials and Methods
Data Collection. To develop and evaluate our model for
classifying lung adenocarcinoma histology patterns, we col-
lected whole-slide images from all patients with a diag-
nosis of lung adenocarcinoma since 2016 who underwent
lobectomies at the Dartmouth-Hitchcock Medical Center
(DHMC), a tertiary academic care center in Lebanon, New
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Hampshire. These histopathology slides contain formalin-
fixed paraffin-embedded tissue specimens and were scanned
by a Leica Aperio whole-slide scanner at 20x magnification
at the Department of Pathology and Laboratory Medicine
at DHMC. In total, 422 whole-slide images were collected
for this study. We randomly partitioned 279 of these images
(about two-thirds of the dataset) for model training, and the
remaining 143 images (about one-third of the dataset) for
model testing.
Slide Annotation. All whole-slide images were manu-
ally labeled by three pathologists from the Department of
Pathology and Laboratory Medicine at DHMC. The 279 im-
ages used for training were further split into a training set
of 245 images and a development set of 34 images. For the
training set, pathologists annotated 4,161 crops from 245
images, about 17 crops per image. These rectangular crops
varied in size (mean: 718 × 771 pixels, standard deviation:
645 × 701 pixels, median: 429 × 473 pixels) and were la-
beled as either one of the five histologic patterns or benign.
Our benign class also included inflammation, scarring, fi-
brosis, and artifacts. For the development set, our pathol-
ogists annotated 1,068 square patches of 224 × 224 pixels
for classic examples of each pattern. Since these patches
are used for model selection and development, all labels
in this set were independently verified by two pathologists,
and patches with disagreements were discarded.
Labeling the independent test set. Our test set is 143
whole-slide images, each of which contains one or more of
the five histological patterns. Our three pathologists inde-
pendently labeled all images on the whole-slide level, spec-
ifying the predominant and minor patterns. After our model
development was completed, we evaluated our model on
this test set and compared its performance to those of our
pathologist annotators. Table 1 shows the class distribution
of crops for the training set, patches for the development
set, and whole-slides for the test set.
Residual neural networks. Deep learning models, such as
convolutional neural networks, have been increasingly ap-
plied to computer vision and medical image analysis due
to breakthroughs in high-performance computing and the
availability of large datasets. In our study, we leverage the
deep residual network (ResNet),37 a type of convolutional
neural network that uses residual blocks to achieve state-
of-the-art performance on image recognition benchmarks
such as ImageNet38 and COCO.39 We implemented ResNet
to take in square patches as inputs and output a prediction
probability for each of the five histological patterns and be-
nign tissue, six classes in total.
Data processing and augmentation. We trained our model
on 4,161 annotated crops from the training set. Because
each of these crops is of variable size, we used a sliding
window algorithm to generate multiple smaller patches of
fixed length and width from each crop. Some classes con-
tained more crops than others, so we generated patches with
different overlapping areas for each class to form a uniform
class distribution. Before inputting a patch into the model
for training, we normalized the color channel values to the
mean and standard deviation of the entire training set to
neutralize color differences between slides. Next, we aug-
mented our training set by performing color jittering on the
brightness, contrast, saturation, and hue of each image. Fi-
nally, we rotated each image by 90◦ and randomly flipped
it across the horizontal and vertical axes. Our final training
set consisted of approximately eight thousand patches per
class.
Training the residual neural network. As for model pa-
rameters, we initialized the network weights with the He
initialization.40 We trained for fifty epochs on the aug-
mented training set, starting with an initial learning rate of
0.001 and decaying by a factor of 0.9 every epoch. Our
model used the multi-class cross-entropy loss function. To
find the optimal depth for the residual network, we con-
ducted an ablation test on ResNets of 18, 34, 50, 101, and
152 layers. We found they all obtain similar accuracies on
our development set, so we chose ResNet-18 since it has
the smallest number of parameters and the fastest training
time. Our final ResNet model for patch classification was
trained in twenty-four hours on an NVIDIA K40c graphics
processing unit (GPU) card.
Whole-slide inference. At inference time, we aimed to de-
tect all predominant and minor patterns at the whole-slide
level. But because our trained ResNet classifies patches,
not entire slides, we first broke down each whole slide into a
collection of patches by sliding a fixed-size window over the
entire image. Patches overlapped by a factor of one-fifth, re-
sulting in a large number of patches for each high-resolution
whole slide (mean = 9,267, standard deviation = 8,351, me-
dian = 7,069). We then classified each patch and filtered
out noise by using thresholding to discard predictions of
low confidence. Thresholds are determined by a grid search
over each pattern class, optimizing for the correspondence
between our model and whole-slide labels on the develop-
ment set. Considering the distribution of the predicted patch
patterns for each slide, we then used a three-step heuristic
to classify the whole slide. First, classes comprising less
than five percent of the patch predictions, as well as the be-
nign class, were dropped. Then, the most frequent class
was assigned to the predominant label. Finally, all remain-
ing cancerous pattern classes were assigned to minor labels.
By discarding predictions of low confidence and aggregat-
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ing over a large number of patches, our model is robust to
artifacts from tissue staining, as well as single-patch mis-
classifications. A schematic overview of the whole-slide
inference process is shown in Figure 1. Evaluation time of
our model for a single whole slide was around thirty sec-
onds.
Statistical analysis and comparison to pathologists. For
final evaluation, we ran our model on the test set of 143
whole-slide images. We also asked our three pathologists to
independently label the predominant and minor patterns in
all 143 whole-slide images. As a result, we had four sets of
whole-slide classifications in total: three from pathologists,
and one from our model. To evaluate the performance of
our model, we compared the concordance of our model’s la-
bels with those of pathologists’ by calculating an interrater
reliability metric called Cohen’s kappa score.41 We chose
Cohen’s kappa score for two reasons. First, because histo-
logic patterns are only determined from subjective reviews
by pathologists, no ground truth labels exist to calculate F1-
scores or AUC. Second, previous studies on classifying his-
tologic patterns use kappa score as a standard metric,19,20
so we follow this convention to facilitate comparison be-
tween our results and those of previous literature. Between
every two sets of annotations, we calculated Kpredom, pre-
dominant agreement, and kappa scores per class. Kpredom
is the kappa score for the predominant pattern. Predomi-
nant agreement is the percentage of whole slides in which
two annotators agreed on the predominant pattern. Kappa
scores per class were calculated for detection of a pattern,
regardless of predominant or minor subtype, between two
sets of annotations. Furthermore, we calculated a metric
called “robust agreement”, which indicates the agreement
for an annotator with at least two of the three other anno-
tators. We performed a two-sample t-test on all pairs of
metrics described above to find any statistically significant
difference among them.
Visualization of predicted patches. We visualized the de-
tected lung adenocarcinoma histologic patterns on whole-
slide images by overlaying color-coded dots on patches for
which our model predicted a histologic pattern. This visual-
ization confirmed the decisions generated by our model and
allowed pathologists to gain insight into our model’s classi-
fication method.
Guidelines and regulations. This study and the use of hu-
man subject data in this project were approved by the Dart-
mouth institutional review board (IRB) with a waiver of in-
formed consent. The conducted research reported in this
paper is in accordance with this approved IRB protocol and
the World Medical Association Declaration of Helsinki on
Ethical Principles for Medical Research Involving Human
Subjects.
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